Clostridium butyricum and Chitooligosaccharides in Synbiotic Combination Ameliorate Symptoms in a DSS-Induced Ulcerative Colitis Mouse Model by Modulating Gut Microbiota and Enhancing Intestinal Barrier Function
Xingxi Huang, Jutuan Hu, Heng Zhang, Ji Li, Xi Zhu, Yangyang Liu, Yunxiang Liang, Yuxia Mei
Abstract
Ulcerative colitis (UC), an idiopathic intestinal disease characterized by continuous remission/relapse inflammatory cycles in the colonic mucosal layer, has strong adverse effects on patients’ quality of life and considerable costs for health care systems. Probiotics, prebiotics, and synbiotics are regarded as potential therapeutic agents for UC, in terms of safety and efficacy.
Topics & Concepts
Clostridium butyricumUlcerative colitisSynbioticsColitisInflammatory bowel diseaseGut floraImmunologyPrebioticMedicineMicrobiologyProbioticInternal medicineBiologyDiseaseBacteriaBiochemistryGeneticsGut microbiota and healthInflammatory Bowel DiseaseGastrointestinal motility and disorders